Antizyme inhibitor 1 Polyclonal antibody

Antizyme inhibitor 1 Polyclonal Antibody for WB, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human, mouse, rat

Applications

WB, IF, IHC, ELISA

Conjugate

Unconjugated

Cat no : 11548-1-AP

Synonyms

Antizyme inhibitor 1, AZIN1, OAZI, OAZIN, ODC1L, AZI, AZI1, AZIN 1


☆対象製品が30%オフ!組換えタンパク質&免染用試薬 >>> キャンペーン実施中!


Tested Applications

Positive WB detected inA549 cells, HepG2 cells, NCI-H1299 cells, PC-3 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:1000-1:6000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

11548-1-AP targets Antizyme inhibitor 1 in WB, IF, IHC, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, rat, mouse
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Antizyme inhibitor 1 fusion protein Ag2082 相同性解析による交差性が予測される生物種
Full Name antizyme inhibitor 1
Calculated molecular weight49.5 kDa
Observed molecular weight 50 kDa
GenBank accession numberBC019279
Gene symbol AZIN1
Gene ID (NCBI) 51582
RRIDAB_2290243
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

Background Information

AZIN1(Antizyme inhibitor 1) is also named as OAZI, OAZIN and belongs to the Orn/Lys/Arg decarboxylase class-II family. It catalyzes the conversion of ornithine to putrescine in the first and apparently rate-limiting step in polyamine biosynthesis, and playing a role in the regulation of polyamine synthesis (negative regulator of cellular polyamines).

Protocols

Product Specific Protocols
WB protocol for Antizyme inhibitor 1 antibody 11548-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Cancer Cell

The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.

Authors - Leng Han
humanWB

J Clin Invest

Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Authors - Anna Bianchi-Smiraglia
humanWB

Mol Ther

Targeting RNA Editing of Antizyme Inhibitor 1: a Potential Oligonucleotide-Based Antisense Therapy for Cancer.

Authors - Daryl Jin Tai Tay
ratWB

Theranostics

Crucial Role of miR-433 in Regulating Cardiac Fibrosis.

Authors - Lichan Tao
mouseWB,IHC

Kidney Int

The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway.

Authors - Li Rong R
humanIHC

FASEB J

The rational discovery of multipurpose inhibitors of the ornithine decarboxylase.

Authors - Xiaoying Chai